These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 34470948)

  • 1. Environmental Risk Assessment of Active Human Pharmaceutical Ingredients in Urban Rivers in Japan.
    Suzuki T; Kosugi Y; Watanabe K; Iida H; Nishimura T
    Chem Pharm Bull (Tokyo); 2021; 69(9):840-853. PubMed ID: 34470948
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Occurrence of selected pharmaceuticals in river water in Japan and assessment of their environmental risk.
    Komori K; Suzuki Y; Minamiyama M; Harada A
    Environ Monit Assess; 2013 Jun; 185(6):4529-36. PubMed ID: 23054265
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seasonal variations of several pharmaceutical residues in surface water and sewage treatment plants of Han River, Korea.
    Choi K; Kim Y; Park J; Park CK; Kim M; Kim HS; Kim P
    Sci Total Environ; 2008 Nov; 405(1-3):120-8. PubMed ID: 18684486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence and fate of pharmaceutically active compounds in the environment, a case study: Höje River in Sweden.
    Bendz D; Paxéus NA; Ginn TR; Loge FJ
    J Hazard Mater; 2005 Jul; 122(3):195-204. PubMed ID: 15967274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass-balance-model-based evaluation of sewage treatment plant contribution to residual pharmaceuticals in environmental waters.
    Hong Y; Lee I; Lee W; Kim H
    Chemosphere; 2019 Jun; 225():378-387. PubMed ID: 30884299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measured and predicted environmental concentrations of carbamazepine, diclofenac, and metoprolol in small and medium rivers in northern Germany.
    Meyer W; Reich M; Beier S; Behrendt J; Gulyas H; Otterpohl R
    Environ Monit Assess; 2016 Aug; 188(8):487. PubMed ID: 27465046
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of measured and predicted environmental concentrations of selected human pharmaceuticals and personal care products.
    Liebig M; Moltmann JF; Knacker T
    Environ Sci Pollut Res Int; 2006 Mar; 13(2):110-9. PubMed ID: 16612900
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Source estimation of pharmaceuticals based on catchment population and in-stream attenuation in Yodo River watershed, Japan.
    Hanamoto S; Nakada N; Yamashita N; Tanaka H
    Sci Total Environ; 2018 Feb; 615():964-971. PubMed ID: 29751447
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Potential Risk and Distribution Characteristics of PPCPs in Surface Water and Sediment from Rivers and Lakes in Beijing, China].
    Zhang PW; Zhou HD; Zhao GF; Li K; Zhao XH; Liu QN; Ren M; Zhao DD; Li DJ
    Huan Jing Ke Xue; 2017 May; 38(5):1852-1862. PubMed ID: 29965089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal and spatial variation in pharmaceutical concentrations in an urban river system.
    Burns EE; Carter LJ; Kolpin DW; Thomas-Oates J; Boxall ABA
    Water Res; 2018 Jun; 137():72-85. PubMed ID: 29544205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmaceuticals in water, fish and osprey nestlings in Delaware River and Bay.
    Bean TG; Rattner BA; Lazarus RS; Day DD; Burket SR; Brooks BW; Haddad SP; Bowerman WW
    Environ Pollut; 2018 Jan; 232():533-545. PubMed ID: 29032907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence and fate of selected anticancer, antimicrobial, and psychotropic pharmaceuticals in an urban river in a subcatchment of the Yodo River basin, Japan.
    Azuma T; Ishiuchi H; Inoyama T; Teranishi Y; Yamaoka M; Sato T; Mino Y
    Environ Sci Pollut Res Int; 2015 Dec; 22(23):18676-86. PubMed ID: 26178832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Occurrence and a screening-level risk assessment of human pharmaceuticals in the Pearl River system, South China.
    Zhao JL; Ying GG; Liu YS; Chen F; Yang JF; Wang L; Yang XB; Stauber JL; Warne MS
    Environ Toxicol Chem; 2010 Jun; 29(6):1377-84. PubMed ID: 20821582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implications of human pharmaceutical occurrence in the Sindian river of Taiwan: a strategic study of risk assessment.
    Lin AY; Panchangam SC; Chen HY
    J Environ Monit; 2010 Jan; 12(1):261-70. PubMed ID: 20082021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Occurrence of 70 pharmaceutical and personal care products in Tone River basin in Japan.
    Nakada N; Komori K; Suzuki Y; Konishi C; Houwa I; Tanaka H
    Water Sci Technol; 2007; 56(12):133-40. PubMed ID: 18075189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Multi-residue analytical method for human pharmaceuticals and synthetic hormones in river water and sewage effluents by solid-phase extraction and liquid chromatography-tandem mass spectrometry.
    Al-Odaini NA; Zakaria MP; Yaziz MI; Surif S
    J Chromatogr A; 2010 Oct; 1217(44):6791-806. PubMed ID: 20851398
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk assessment of triclosan released from sewage treatment plants in European rivers using a combination of risk quotient methodology and Monte Carlo simulation.
    Thomaidi VS; Matsoukas C; Stasinakis AS
    Sci Total Environ; 2017 Dec; 603-604():487-494. PubMed ID: 28641188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaceutical pollution of the world's rivers.
    Wilkinson JL; Boxall ABA; Kolpin DW; Leung KMY; Lai RWS; Galbán-Malagón C; Adell AD; Mondon J; Metian M; Marchant RA; Bouzas-Monroy A; Cuni-Sanchez A; Coors A; Carriquiriborde P; Rojo M; Gordon C; Cara M; Moermond M; Luarte T; Petrosyan V; Perikhanyan Y; Mahon CS; McGurk CJ; Hofmann T; Kormoker T; Iniguez V; Guzman-Otazo J; Tavares JL; Gildasio De Figueiredo F; Razzolini MTP; Dougnon V; Gbaguidi G; Traoré O; Blais JM; Kimpe LE; Wong M; Wong D; Ntchantcho R; Pizarro J; Ying GG; Chen CE; Páez M; Martínez-Lara J; Otamonga JP; Poté J; Ifo SA; Wilson P; Echeverría-Sáenz S; Udikovic-Kolic N; Milakovic M; Fatta-Kassinos D; Ioannou-Ttofa L; Belušová V; Vymazal J; Cárdenas-Bustamante M; Kassa BA; Garric J; Chaumot A; Gibba P; Kunchulia I; Seidensticker S; Lyberatos G; Halldórsson HP; Melling M; Shashidhar T; Lamba M; Nastiti A; Supriatin A; Pourang N; Abedini A; Abdullah O; Gharbia SS; Pilla F; Chefetz B; Topaz T; Yao KM; Aubakirova B; Beisenova R; Olaka L; Mulu JK; Chatanga P; Ntuli V; Blama NT; Sherif S; Aris AZ; Looi LJ; Niang M; Traore ST; Oldenkamp R; Ogunbanwo O; Ashfaq M; Iqbal M; Abdeen Z; O'Dea A; Morales-Saldaña JM; Custodio M; de la Cruz H; Navarrete I; Carvalho F; Gogra AB; Koroma BM; Cerkvenik-Flajs V; Gombač M; Thwala M; Choi K; Kang H; Ladu JLC; Rico A; Amerasinghe P; Sobek A; Horlitz G; Zenker AK; King AC; Jiang JJ; Kariuki R; Tumbo M; Tezel U; Onay TT; Lejju JB; Vystavna Y; Vergeles Y; Heinzen H; Pérez-Parada A; Sims DB; Figy M; Good D; Teta C
    Proc Natl Acad Sci U S A; 2022 Feb; 119(8):. PubMed ID: 35165193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are exposure predictions, used for the prioritization of pharmaceuticals in the environment, fit for purpose?
    Burns EE; Thomas-Oates J; Kolpin DW; Furlong ET; Boxall ABA
    Environ Toxicol Chem; 2017 Oct; 36(10):2823-2832. PubMed ID: 28477358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence of antidepressant residues in the sewage-impacted Vistula and Utrata rivers and in tap water in Warsaw (Poland).
    Giebułtowicz J; Nałęcz-Jawecki G
    Ecotoxicol Environ Saf; 2014 Jun; 104():103-9. PubMed ID: 24636953
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.